Table 4.
Linear regression analysis between HbA1c, FPG, and selected indicators of cardiometabolic risk factors.
| Variable | HbA1c | FPG | ||
|---|---|---|---|---|
| β | r2 | β | r2 | |
| SBP (mmHg) | 0.58 | 0.00 | 4.10∗∗ | 0.06 |
| DBP (mmHg) | -0.26 | 0.00 | 2.17∗ | 0.03 |
| HbA1dc-Dcct (%) | - | - | 0.12 | 0.01 |
| FPG (mmol/L) | 0.07 | 0.01 | - | - |
| Total cholesterol (mmol/L) | 0.07 | 0.00 | 0.33∗∗ | 0.05 |
| Triglyceride (mmol/L) | 0.12∗ | 0.03 | 0.21∗∗ | 0.05 |
| HDL-c (mmol/L) | 0.00 | 0.00 | 0.22 | 0.04 |
| LDL-c (mmol/L) | 0.02 | 0.00 | 0.01 | 0.00 |
| VLDL-c (mmol/L) | 0.05∗ | 0.03 | 0.10∗∗ | 0.05 |
| MetS score | 0.06 | 0.00 | 0.56∗∗∗ | 0.20 |
∗Regression is significant at the 0.05 level, ∗∗regression is significant at the 0.01 level, and ∗∗∗regression is significant at the 0.001 level.